- Home
- CSAN vs INDV Comparison
CSAN vs INDV Comparison
Compare CSAN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSAN | INDV |
|---|---|---|
| Founded | 1936 | 1994 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CSAN | INDV |
|---|---|---|
| Price | $4.44 | $34.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.75 | ★ $35.75 |
| AVG Volume (30 Days) | ★ 2.4M | 1.7M |
| Earning Date | 02-25-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | ★ $7,988,294,917.00 | $1,180,000,000.00 |
| Revenue This Year | $270.61 | $2.27 |
| Revenue Next Year | $0.31 | N/A |
| P/E Ratio | ★ N/A | $33.60 |
| Revenue Growth | ★ 2.13 | N/A |
| 52 Week Low | $3.72 | $7.62 |
| 52 Week High | $6.25 | $38.00 |
Technical Indicators
Market Signals| Indicator | CSAN | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 50.16 |
| Support Level | $4.37 | $34.31 |
| Resistance Level | $4.69 | $36.03 |
| Average True Range (ATR) | 0.17 | 1.08 |
| MACD | 0.06 | 0.13 |
| Stochastic Oscillator | 70.87 | 64.90 |
Price Performance
Historical ComparisonAbout CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.